Delcath Systems, Inc., a pioneering company in the field of oncology, is headquartered in the United States. Founded in 1988, Delcath has established itself as a leader in the development of innovative therapies for cancer treatment, particularly through its proprietary ChemoSat® system. This unique technology allows for targeted delivery of chemotherapy directly to tumours, minimising systemic exposure and enhancing treatment efficacy. With a focus on liver cancer and other solid tumours, Delcath operates primarily in North America and Europe, positioning itself as a key player in the oncology market. The company has achieved significant milestones, including regulatory approvals that underscore its commitment to advancing cancer care. Delcath's dedication to improving patient outcomes and its innovative approach to treatment continue to set it apart in the competitive landscape of cancer therapeutics.
How does Delcath Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Delcath Systems, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Delcath Systems, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Delcath Systems may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for Delcath Systems to consider developing and communicating its climate commitments to align with broader environmental goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Delcath Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
